SB-258585

SB-258585 is a drug that acts as a potent and selective antagonist for the 5-HT6 receptor. It has been used in scientific research to explore the role of 5-HT6 in the brain, and has been found to produce cognitive enhancing effects in animal studies.

Pharmacology

SB-258585 is a 5-HT6 receptor antagonist. The 5-HT6 receptor is a subtype of the 5-HT receptor that binds the endogenous neurotransmitter serotonin. It is thought to be involved in the regulation of cognition, mood, and anxiety, among other functions.

In animal studies, SB-258585 has been found to enhance cognitive performance. This effect is thought to be mediated by its action on the 5-HT6 receptor, although the exact mechanisms are not fully understood.

Research

Research into the effects of SB-258585 has primarily focused on its potential as a treatment for cognitive disorders such as Alzheimer's disease and schizophrenia. In animal models of these conditions, SB-258585 has been found to improve cognitive performance.

In addition to its potential therapeutic applications, SB-258585 has also been used as a tool in scientific research to better understand the role of the 5-HT6 receptor in the brain.

See also

• 5-HT6 receptor
• Serotonin
• Cognition
• Alzheimer's disease
• Schizophrenia

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  SB-258585